These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8684093)

  • 1. Biotech's uncertain present.
    Lancet; 1996 Jun; 347(9014):1497. PubMed ID: 8684093
    [No Abstract]   [Full Text] [Related]  

  • 2. Is British Biotech's Marimastat a major cancer drug?
    Davidson S
    Nat Biotechnol; 1996 Jul; 14(7):819-20. PubMed ID: 9630998
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotech's wellspring: the health of private biotech in 2013.
    Huggett B
    Nat Biotechnol; 2014 May; 32(5):428-35. PubMed ID: 24811512
    [No Abstract]   [Full Text] [Related]  

  • 4. A blueprint for biotech's blues.
    Nat Biotechnol; 2009 Aug; 27(8):675. PubMed ID: 19668152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotech's wonder ride.
    Rynecki D
    Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech's baby boom.
    Hodgson J
    Nat Biotechnol; 2019 May; 37(5):502-512. PubMed ID: 31053818
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech's billion dollar breakthrough.
    Stipp D
    Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
    [No Abstract]   [Full Text] [Related]  

  • 8. Crystal gazing: biotech's financial outlook: the biotech analyst's view.
    Schmidt E
    Nat Biotechnol; 2006 Mar; 24(3):261-2. PubMed ID: 16525376
    [No Abstract]   [Full Text] [Related]  

  • 9. Big pharma swallows biotech's pride.
    Huggett B
    Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
    [No Abstract]   [Full Text] [Related]  

  • 10. Indian biotech's bumpy road.
    Basu P
    Nature; 2007 Nov; 450(7169):580-1. PubMed ID: 18087777
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech's wellspring: a survey of the health of the private sector.
    Huggett B
    Nat Biotechnol; 2012 May; 30(5):395-400. PubMed ID: 22565961
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotech's perfect storm.
    Karberg S
    Cell; 2009 Aug; 138(3):413-5. PubMed ID: 19665960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroesophageal cancer, palmar fasciitis and a matrix metalloproteinase inhibitor.
    Virik K; Lynch KP; Harper P
    Intern Med J; 2002; 32(1-2):50-1. PubMed ID: 11783676
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotech's fallen angels.
    Duane J; Ma P
    Nat Rev Drug Discov; 2003 Apr; 2(4):255-6. PubMed ID: 12680369
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech's balancing act.
    Smaglik P
    Nature; 2003 May; 423(6937):363. PubMed ID: 12748656
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progress in diagnosis and treatment of lung cancer].
    Fukuoka M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():15-22. PubMed ID: 11989256
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotech's wellspring-a survey of the health of the private sector in 2016.
    Lawrence S
    Nat Biotechnol; 2017 May; 35(5):413-420. PubMed ID: 28486451
    [No Abstract]   [Full Text] [Related]  

  • 18. Marimastat therapy as adjuvant to selective embolization in skeletal metastases of differentiated thyroid carcinoma.
    Smit JW; van Tol KM; Hew JM; Vielvoye GJ; Romijn JA; Links TP
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):421-2. PubMed ID: 11589688
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotech's gender gap.
    Littlehales C
    Nat Biotechnol; 2005 Sep; 23(9):1041-2. PubMed ID: 16222766
    [No Abstract]   [Full Text] [Related]  

  • 20. Silent running: the race to the clinic.
    Nature; 2006 Aug; 442(7103):614-5. PubMed ID: 16900171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.